Top compounds associated with response to RPS2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.07
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.07
mRNA KPT185 CTRPv2 pan-cancer AAC 0.069 0.07
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.067 0.07
mRNA thalidomide CTRPv2 pan-cancer AAC -0.096 0.08
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.065 0.08
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 0.08
mRNA manumycin A CTRPv2 pan-cancer AAC 0.057 0.08
mRNA Imatinib CTRPv2 pan-cancer AAC 0.064 0.08
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC -0.068 0.08
Download CSV